Cargando…

Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone

OBJECTIVE: This study aimed to assess the efficacy of aripiprazole for the management of cognitive impairments and hyperprolactinemia in patients with schizophrenia on a stable dose of risperidone. METHODS: Thirty-five subjects stabilized on risperidone (3-6 mg/day) for a minimum of 3 months were en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Bong Ju, Lee, Seung Ju, Kim, Min Kyung, Lee, Jung Goo, Park, Sung Woo, Kim, Gyung Mee, Kim, Young Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766756/ https://www.ncbi.nlm.nih.gov/pubmed/24023549 http://dx.doi.org/10.9758/cpn.2013.11.2.60

Ejemplares similares

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
por: Tasaki, Minami, et al.
Publicado: (2021)

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar, Fatemeh, et al.
Publicado: (2015)

Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study
por: Lee, Jung Goo, et al.
Publicado: (2012)

Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial
por: Zhao, Jingyuan, et al.
Publicado: (2015)

PM403. Comparison between addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia
por: Lee, Jung Suk, et al.
Publicado: (2016)

Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
por: Bise, S., et al.
Publicado: (2022)

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
por: Hongkaew, Yaowaluck, et al.
Publicado: (2015)

Effectiveness of Switching to Long-acting Injectable Aripiprazole in Patients with Recent-onset and Chronic Schizophrenia
por: Kim, Sung-Wan, et al.
Publicado: (2023)

A Comparative Study of Short Term Efficacy of Aripiprazole and Risperidone in Schizophrenia
por: Pandey, Ravi S., et al.
Publicado: (2017)

Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole
por: Kotorki, Paraskevi, et al.
Publicado: (2010)

Idiopathic granulomatous mastitis associated with risperidone-induced hyperprolactinemia
por: Lin, Chih-Hsun, et al.
Publicado: (2012)

Risperidone Induced Hyperprolactinemia: From Basic to Clinical Studies
por: Stojkovic, Milena, et al.
Publicado: (2022)

Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia
por: Raveendranthan, Dhanya, et al.
Publicado: (2018)

Aripiprazole-induced Hyperprolactinemia in a Young Female with Delusional Disorder
por: Joseph, Sam Padamadan
Publicado: (2016)

Management of risperidone-induced hyperprolactinemia in children: a case report
por: Belhadga, H., et al.
Publicado: (2023)

PM402. Factors associated with sexual health in Korean patients with schizophrenia receiving risperidone monotherapy
por: Lee, Ju-Yeon, et al.
Publicado: (2016)

The Difference of Fasting Blood Sugar of Male Patients with Schizophrenia Treated with Flexible Dose between Aripiprazole and Risperidone in Medan, Indonesia
por: Marni, Trisna, et al.
Publicado: (2019)

Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
por: Kelly, Deanna L, et al.
Publicado: (2013)

Clinical Usefulness of Aripiprazole and Lamotrigine in Schizoaffective Presentation of Tuberous Sclerosis
por: Lee, Seung-Yup, et al.
Publicado: (2016)

Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based study
por: Gianfrancesco, Frank D, et al.
Publicado: (2009)

A Comment on “Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia”
por: Naguy, Ahmed
Publicado: (2018)

Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids
por: He, Sidi, et al.
Publicado: (2020)

Comparison the effectiveness of aripiprazole and risperidone for the treatment of acute bipolar mania
por: Rezayat, Amir Akhavan, et al.
Publicado: (2014)

Review of depot aripiprazole for schizophrenia
por: Motiwala, Farha Bilal, et al.
Publicado: (2013)

Immunotoxicological Effects of Aripiprazole: In vivo and In vitro Studies
por: Baek, Kwang-Soo, et al.
Publicado: (2015)

RISPERIDONE IN SCHIZOPHRENIA
por: Agashe, Mohan, et al.
Publicado: (1999)

RISPERIDONE IN SCHIZOPHRENIA
por: Kumar, P.N. Suresh
Publicado: (1999)

Adjunctive Aripiprazole Versus Placebo for Antipsychotic-Induced Hyperprolactinemia: Meta-Analysis of Randomized Controlled Trials
por: Li, Xianbin, et al.
Publicado: (2013)

The Short-Term Effects of Risperidone-Induced Hyperprolactinemia on Lipid Metabolism in Drug-Naïve Children and Adolescents
por: Park, Eun Jin, et al.
Publicado: (2015)

The relationship between dopamine receptor blockade and cognitive performance in schizophrenia: a [(11)C]-raclopride PET study with aripiprazole
por: Shin, Sangho, et al.
Publicado: (2018)

Tardive Dystonia Related with Aripiprazole
por: Kim, Sunghwan, et al.
Publicado: (2017)

PS200. Effects of p11 on BDNF-induced changes in dendritic outgrowth and spine formation in primary hippocampal cells
por: Seo, Mi Kyoung, et al.
Publicado: (2016)

Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials
por: MENG, Meiling, et al.
Publicado: (2015)

Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells
por: Racki, Valentino, et al.
Publicado: (2021)

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
por: Soria-Chacartegui, Paula, et al.
Publicado: (2021)

PS114. Effects of Tianeptine on mTOR Signaling in Rat Hippocampal Neurons
por: Seo, Mi Kyoung, et al.
Publicado: (2016)

Retrospective Study of Japanese Patients with Schizophrenia Treated with Aripiprazole
por: Tanioka, Tetsuya, et al.
Publicado: (2012)

Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
por: Raghuthaman, G., et al.
Publicado: (2015)

Behavioral Mechanisms That Depend on Dopamine and Serotonin in Caenorhabditis elegans Interact With the Antipsychotics Risperidone and Aripiprazole
por: Osuna-Luque, Jaime, et al.
Publicado: (2018)

Aripiprazole for late-life schizophrenia
por: Rado, Jeffrey, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tl1n762afu208pbvlj0cmoeqqu